Search

Search Results

• 

  Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma

  D. Fanni, M. Manchia, F. Lai, C. Gerosa, R. Ambu, G. Faa

  11-04-2016

  https://doi.org/10.4081/ejh.2016.2614

  2316

  PDF: 828

  HTML: 415
• 

  MiR-130a-5p contributed to the progression of endothelial cell injury by regulating FAS

  Wei Wang, Wenbo Tang, Erbo Shan, Lei Zhang, Shiyuan Chen, Chaowen Yu, Yong Gao

  31-05-2022

  https://doi.org/10.4081/ejh.2022.3342

  1079

  PDF: 683

  HTML: 27

• P43 | NEW INSIGHTS IN THE ACTIVATION OF FERROPTOSIS PROCESS DURING LIVER FIBROSIS R. Mancinelli¹, S. Leone¹, A. Casini¹, R. Vaccaro¹, M. Tagliafierro¹, F.M. Bassi¹, E. Bocci¹, S. Vitale¹, A. Franchitto², L. Pannarale¹, P. Onori¹, E. Gaudio¹ | ¹Department of Anatomical, Histological, Forensic Medicine and Orthopaedics Sciences, Sapienza University of Rome, Italy; ²Division of Health Sciences, Department of Movement, Human and Health Sciences, University of Rome Foro Italico, Italy

  21-08-2025

  https://doi.org/10.4081/ejh.2025.4365

  195
• 

  MiR-122-5p inhibits the epithelial mesenchymal transition of liver cancer cells by inducing hiPSCs to differentiate into hepatocyte-like cells

  Qianzhe Xing, Yanjie Xu, Ying Luo, Chenglong Li, Peng Wang, Bin Kang, Chengjun Lu

  06-05-2025

  https://doi.org/10.4081/ejh.2025.4190

  665

  PDF: 347

  HTML: 30
• 

  Effects of piperlonguminine on lung injury in severe acute pancreatitis via the TLR4/NF-κB pathway

  Qian Hu, Ran Tao, Xiaoyun Hu, Haibo Wu, Jianjun Xu

  20-03-2023

  https://doi.org/10.4081/ejh.2023.3639

  1151

  PDF: 682

  HTML: 22